SC rejects Novartis plea on Cancer drug patent

Now watching

Next video starts in : 7 Play

SC rejects Novartis plea on Cancer drug patent


SC rejects Novartis plea on Cancer drug patent
Replay video
Up next

Todd Rundgren LIVE Concert

Unlock your personal NFL Now stream by signing in to NFL.com

SC rejects Novartis plea on Cancer drug patent

by Ani 2:12 mins

SC rejects Novartis plea on Cancer drug patent

by Ani 2:12 mins

The Supreme Court on Monday rejected a plea by Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India. The Bench dismissed the plea that primarily focuses on demands by major companies that their investments be protected, against Indian companies demanding they should be allowed to continue producing cheaper indigenous generic versions of many lifesaving medicines. The patents would be granted only for genuine inventions, cited the Supreme Court, a decision that paves way for Indian companies to manufacture generic drugs for cancer.

Must Watch

Must Watch

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

Other Space

  1. 27:05

    Other Space Episode 1: Into the Great Beyond...Beyond

  2. 25:20

    Other Space Episode 2: Getting to Know You

  3. 25:51

    Other Space Episode 3: The Death of A.R.T.

  4. 25:46

    Other Space Episode 4: Ted Talks

  5. 26:44

    Other Space Episode 5: Trouble's Brewing

  6. 27:02

    Other Space Episode 6: Powerless

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 30:58

    Community Episode 4: Queer Studies and Advanced Waxing

  5. 28:45

    Community Episode 5: Laws of Robotics and Party Rights

  6. 28:13

    Community Episode 6: Basic Email Security